Sphera Funds Management »

Rapport Therapeutics shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.7M 158k 29.70

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Nice Sponsored Adr (NICE)
Tower Semiconductor Shs New (TSEM)
Cidara Therapeutics Com New (CDTX)
Merus N V Call Option (MRUS)
NOVA MEASURING Instruments L (NVMI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Biogen Idec (BIIB)
Ultragenyx Pharmaceutical (RARE)
Astrazeneca Sponsored Adr (AZN)
Sanofi Sa Sponsored Adr (SNY)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Mineralys Therapeutics (MLYS)
Amicus Therapeutics (FOLD)

View all positions for Sphera Funds Management

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics